How Synthetic DNA Can Help Combat Antibiotic Resistance

Posted by Nat Connors on 11/30/16 11:30 AM

Antibiotic resistance is a growing problem in our world. Devin Leake, Vice President of Research and Development at Gen9, weighs in on how synthetic biology--and specifically long-length synthetic DNA constructs--can combat the issue of antibiotic resistance.

Read More

Topics: Synthetic Biology, Gene Synthesis, DNA Synthesis

Gen9 Named #31 on  Biofuels Digest  List of 40 Hottest Emerging Companies

Posted by Nat Connors on 11/22/16 2:24 PM

Earlier this month, Gen9 was named #31 on Biofuels Digest’s list of the top 40 Hottest Emerging Companies in the Advanced Bioeconomy. The "Hot 40" companies were determined by voters and international panelists. Since 2008, over 100,000 individual company ratings have been evaluated in the annual contest, which recognizes smaller, emerging companies founded in the past 7 years.

Read More

Topics: Synthetic Biology

G-Prize Check-in: How Industrial Microbes Used 500kb of Synthetic DNA

Posted by Nat Connors on 11/15/16 11:00 AM
We caught up with Noah Helman, co-founder and Chief Scientific Officer at Industrial Microbes, to learn how the company has utilized the 500kb of synthetic DNA that the company was awarded in the 4th Annual G-Prize competition for synthetic biology.
Read More

Topics: Synthetic Biology, G-Prize, DNA Synthesis

Longest Synthetic Virus Could Be A Breakthrough In Treating Canine Cancer

Posted by Nat Connors on 11/8/16 1:00 PM

“I don’t want to overstate it, but it’s a revolution – a complete revolution,” said Bruce Smith, V.M.D., Ph.D. “Eventually, you will treat cancer patients with chemotherapy and a therapeutic virus that is customized to their tumor. If the tumor were to come back, you would resequence, create a new therapeutic virus, then treat the patient again. It completely changes the way we will manage cancer.”

Read More

Topics: Gene Synthesis, DNA Synthesis

Microbes of the Future  Shine at HUBweek

Posted by Nat Connors on 10/3/16 11:02 AM

 Yesterday, Gen9 President and CEO Kevin Munnelly joined Jason Kelly of Ginkgo Bioworks and Jasmina Aganovic of Mother Dirt for Microbes of the Future, a HUBweek event focused on the synthetic biology market and the future of the field.

Read More

SynBioBeta San Francisco 2016: A Preview

Posted by Nat Connors on 9/30/16 11:18 AM
We're thrilled to be Gold Sponsors at SynBioBeta San Francisco next week! It will be an action packed few days featuring a Gen9 sponsored workshop, reception, and our VP of Research and Development, Devin Leake, on a DNA data storage panel. 
Read More

Getting to Breakthroughs Faster with Mass Quantities of Synthetic DNA

Posted by Nat Connors on 8/11/16 10:03 AM
In this video, Patrick Boyle, Head of Design at Ginkgo Bioworks, discusses how mass quantities of synthetic DNA speed his design-build-test cycles and how long-length DNA constructs open up design possibilities in synthetic biology research.
Read More

Topics: Synthetic Biology, Gene Synthesis, DNA Synthesis

SynBio Conversations: Sajith  Wickramasekara, Benchling (Part 2)

Posted by Nat Connors on 8/9/16 9:57 AM

As part of our continuing synthetic biology conversations series, we spoke with Saji Wickramasekara, Founder and CEO of Benchling, a San Francisco-based company working to make life science research faster and more collaborative. The following is part two of our two-part conversation with Saji.

Read More

Topics: Synthetic Biology, DNA Design, Benchling

SynBio Conversations: Sajith Wickramasekara, Benchling (Part 1)

Posted by Nat Connors on 8/4/16 3:30 PM

As part of our continuing synthetic biology conversations series, we spoke with Saji Wickramasekara, Founder and CEO of Benchling, a San Francisco-based company working to make life science research faster and more collaborative. The following is part one of our two-part conversation with Saji.

Read More

Topics: Synthetic Biology, DNA Design, Benchling

The Power of DNA Synthesis: A Video

Posted by Nat Connors on 7/6/16 3:51 PM

A few weeks back, we announced that we'd signed a partnership with Ginkgo Bioworks to deliver 300 million base pairs of DNA through 2017. This unprecedented deal has been thought-provoking in many ways, and we’ve had some great questions arise from the synbio community and beyond. What will Ginkgo do with 300 megabases of content? How can Gen9 manufacture all that DNA? What could I do with pathway-length constructs like the ones Ginkgo uses?

We sat down with leaders at Ginkgo and Gen9 to learn more about what the partnership means for the future of synthetic biology.

Read More

Topics: Synthetic Biology, Gene Synthesis, Clonal, DNA Synthesis, DNA Design

Start the Conversation

Gen9's Blog

Founded by pioneering scientists in fabrication, genetics, and bio-engineering, the Gen9 vision is one of democratizing synthetic biology. Our goal is to enable broad adoption of powerful synthetic biology techniques by providing custom DNA constructs of the highest possible quality. 

This blog will serve as a platform to:

  • Educate our readers about the goings-on at Gen9
  • Keep our followers up-to-date with service updates and product enhancements
  • Share our views on current events in the Synthetic Biology world

Subscribe to Email Updates